User profiles for Michael Mina

Michael J. Mina, MD, PhD

Harvard School of Public Health, Harvard Medical School
Verified email at hsph.harvard.edu
Cited by 8068

[HTML][HTML] Rethinking Covid-19 test sensitivity—a strategy for containment

MJ Mina, R Parker, DB Larremore - New England Journal of …, 2020 - Mass Medical Soc
Rethinking Covid-19 Test Sensitivity As Covid-19 cases accelerate or plateau around the
world, we urgently need a point-of-care test that is inexpensive enough to use frequently, even …

Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening

…, S Shehata, JM Burke, JA Hay, M Tambe, MJ Mina… - Science …, 2021 - science.org
The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can
spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the …

Estimating epidemiologic dynamics from cross-sectional viral load distributions

…, NJ Lennon, SB Gabriel, M Lipsitch, MJ Mina - Science, 2021 - science.org
Estimating an epidemic’s trajectory is crucial for developing public health responses to
infectious diseases, but case data used for such estimation are confounded by variable testing …

To interpret the SARS-CoV-2 test, consider the cycle threshold value

MR Tom, MJ Mina - Clinical Infectious Diseases, 2020 - academic.oup.com
… Correspondence: MJ Mina, Harvard TH Chan School of Public Health, Kresge Building
506D, 677 Huntington Ave, Boston, MA 02115 (mmina@hsph.harvard.edu). … Tom1 and …

COVID-19 testing: One size does not fit all

MJ Mina, KG Andersen - Science, 2021 - science.org
Tests for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were
developed within days of the release of the virus genome (1). Multiple countries have been …

[HTML][HTML] Antibody testing will enhance the power and accuracy of COVID-19-prevention trials

M Lipsitch, R Kahn, MJ Mina - Nature Medicine, 2020 - nature.com
Researchers starting clinical trials of prevention measures for COVID-19 have a unique window
of opportunity for collecting blood from the participants, at baseline and at the end of the …

[HTML][HTML] Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19

MJ Mina, TE Peto, M García-Fiñana, MG Semple… - The Lancet, 2021 - thelancet.com
1 Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute
coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart …

Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens

MJ Mina, T Kula, Y Leng, M Li, RD De Vries, M Knip… - Science, 2019 - science.org
Measles virus is directly responsible for more than 100,000 deaths yearly. Epidemiological
studies have associated measles with increased morbidity and mortality for years after …

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

K Bjornevik, M Cortese, BC Healy, J Kuhle, MJ Mina… - Science, 2022 - science.org
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr …

Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality

MJ Mina, CJE Metcalf, RL De Swart, A Osterhaus… - Science, 2015 - science.org
Immunosuppression after measles is known to predispose people to opportunistic infections
for a period of several weeks to months. Using population-level data, we show that measles …